Session 992: Screening

Date: 3 February 2004, Time: 11:30 - 13:30
Location: Room 2

Oral Presentations

Time	Number	Title / Authors / Affiliations
11:30	300	A Canadian community pilot comparing primary care physician recruitment to public health unit program recruitment for colorectal screening by fecal occult blood testing in Ontario T Sullivan PhD^a, L Paszat MD^a,b, MD Mai^a, L Rabanek MD^a,b,c, P Ritvo PhD^a, A Hudson MD^a (a) Cancer Care Ontario; (b) Institute for Clinical Evaluative Sciences; (c) Division of Gastroenterology, University of Toronto;
11:50	301	The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States. M Schootman PhD^a,b, D Jeffe PhD^a,b, A Reschke PhD^a,b, R Aft MD^b,c,d (a) Division of Health Behavior Research Departments of Pediatrics and Medicine Washington University School of Medicine; (b) The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine Saint Louis, MO; (c) Section of Surgical Oncology and Endocrinology Department of Surgery Washington University School of Medicine; (d) John Crochran VA Medical Center Saint Louis, MO
12:05	302	Comparing attendance and detection rate of different screening strategies for colorectal cancer N Segnan MD MS^a, C Senore MD MSc^a, B Andreoni MD^b, L Bisanti MD^c, G Castiglione MD^d, A Ferrari MD^e, S Gasperoni MD^f, G Malfitana MD^g, R Ferraris MD^h, S Recchia MDⁱ, G Saracco MD^j, M Spandre MD^k, P Turco MS^l ^aCPO Piemonte, Torino, Firenze, ^bSurgery Unit II, Istituto Europeo di Oncologia, Milano, Firenze, ^cEpidemiology Unit. ASL "Citta' di Milano", Milano, Firenze, ^dGastroenterology Unit, CSPO, Firenze, ^eGastroenterology Unit, Maria Vittoria Hospital, Torino, Rimini, ^fGastroenterology Unit, Infermi Hospital, AUSL Rimini, Rimini, ^gGastroenterology Unit, Infermi Hospital, ASL 12, Biella, ^hGastroenterology Unit, Mauriziano "Umberto I"Hospital, Torino, Firenze, ⁱGastroenterology Unit, S Giovanni Bosco Hospital, Torino, Firenze, ^jGastroenterology Unit, S Giovanni Battista-Molinette Hospital, Torino, Firenze, ^kGastroenterology Unit, S Giovanni Antica Sede, Hospital, Torino, Firenze, ^lCitopathology Unit, CSPO, Firenze, Italy
12:20	303	Distribution of colorectal cancers and adenomas in a screened population and the effectiveness of flexible sigmoidoscopy as a lone screening tool DAL Macafee*, MRCS (a); JH Scholefield, FRCS (a); DK Whynes, BA, BPh (b) ^aDivision of GI Surgery, Queens Medical Centre, Nottingham, United Kingdom, ^bDepartment of Economics, University of Nottingham, Nottingham, United Kingdom
12:35	304	Cytological screening and 15 years’ follow-up (1986-2001) for early esophageal cancer and precancerous lesions in a high-risk population in Anyang County, Henan Province, northern China LD Wang MD^a, ZM Fan MS^a, HH Yang MD^b, YJ Li MD^a, JX Li MD^a, XD Lü MD^a, JK Wang MD^a, XL Liu MD^a, YN Jiang MD^a, Z Sun MD^a, JW Zhou MD^a, SS Gao MS^a, X He MS^a, HQ Guo MS^a (a)Laboratory for Cancer Research, College of Medicine, Zhengzhou University, Zhengzhou, Henan 450052, China and (b)Department of Pathology, Anyang Tumor Hospital, Anyang, Henan, China
12:50	305	Evaluation of positron emission tomography (PET) imaging using fluorine-18 fluorodeoxyglucose (18FDG) for prediction tumor aggressiveness and clinical outcome in lymphoid tumors. J Murakami MD^a, N Watanabe MD^b, T Katou MD, T Miyazono MD, K Ebata MD, Y Shimizu MD, A Watanabe MD^a, M Shimizu MD, H Seto MD^b, S Ishizawa MD, Y Takano MD^c ^aInternal Medicine 3, ^bRadiology, ^cPathology; Toyama Medical and Pharmaceutical University, Toyama, Japan

Poster Presentations

Number	Title / Authors / Affiliations
311	Preliminary results from the Canadian Cervical Cancer Screening Trial (CCCaST Study) E Duarte-Franco MD MPH^a,b, MH Mayrand MD MSc^c,d, F Coutlée MD PhD^e, S Ratnam MD^f, MD Rodrigues MPH^g, SD Walter PhD^h, A Ferenczy MDⁱ, EL Franco PhD^a,c ^aDepartment of Oncology, ^bDepartment of Family Medicine, ^cDepartment of Epidemiology and Biostatistics; McGill University, Montreal, Montreal, ^dDepartment of Obstetrics and Gynecology, CHUM, Montreal, ^eDepartment of Microbiology and Immunology, Université de Montreal, St. John’s, Newfoundland, Canada, ^fNewfoundland Public Health Laboratory, St. John’s, Newfoundland, Canada, ^gDepartment of Family Medicine, Université de Montreal, Hamilton, Ontario, Canada, ^hDepartment of Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada, ⁱDepartment of Pathology, McGill University, Montreal, Quebec, Canada
312	Cervical Cancer Screening Among Urban Brazilian Women. EC Mauad MD^a, UA Gomes MD^b, AGF Melani MD^a,c, SR Morini MD^a,d, MV Denadai MD^a,e (a) Department of Clinical Oncology, Fundação Pio XII – Hospital de Câncer de Barretos, Barretos-Brazil, (b) Faculdade de Medicina de Ribeirão Preto (USP), Ribeirão Preto, São Paulo, Brazil, (c) Department of Gynecological Oncology, (d) Department of Anatomic Pathology, and (e) Department of Surgery
313	Cervical Cancer Screenning Among Rural Brazilian Women UA Gomes, MD (a); EC Mauad *, MD (b); AGF Melani, MD (b,c); GS Hidalgo, MD (b,d); CAR Véo, MD (b,e) (a) Faculdade de Medicina de Ribeirão Preto (USP), (b) Department of Clinical Oncology, Fundação Pio XII – Hospital de Câncer de Barretos, Barretos-Brazil, (c) Department of Gynecological Oncology, (d) Department of Anatomic Pathology, (e) Department of Surgery
314	High risk Human Papillomavirus Infection among normal women from various Indian population: A comparative profile *C Duttagupta, PhD (a); S Sengupta, PhD (a); M Roy, MSc (a); P Bhattacharya, MSc (a); P Laikangbam, MSc (a); D Sengupta, PhD (b); S Roy, MD, DRC, Path (c); S Ghosh, FRCOG (d); TD Singh, MD, Path (e); BB Singh, MBBS (f); Y Verma, MD, Path (g); A Sengupta, MD, PhD (h) ^aBiochemistry Unit, ^bStatistics & Mathematics Unit; Indian Statistical Institute, Calcutta, W. Bengal, ^cDirector, Quadra Diagnostic Centre, Calcutta, W. Bengal, ^dFormer Director, Gynecological Service, Cancer Centre & Welfare Home, Thakurpukur, W. Bengal, ^eBabina Diagnostiic Centre, Manipur, Chhattish Garh, ^fLeirik Memorial Hospital, Manipur, Chhattish Garh, ^gDepartment of Pathology, STNM Hospital, Sikkim, Chhattish Garh, ^hVivekananda Tribal Hospital, Jagdalpur, Chhattish Garh, India
315	A review of the Nottingham faecal occult blood (FOBT) screening trial and its associated economic evaluations DAL Macafee*, MRCS (a); DK Whynes, BA, BPh (b); JH Scholefield, FRCS ^aDivision of GI Surgery, Queens Medical Centre, Nottingham, United Kingdom, ^bDepartment of Economics, University of Nottingham, Nottingham, United Kingdom
316	Histopathologic findings of women with abnormal uterine bleeding in Shiraz, Southern Iran, 2002. S Shekarforoosh MSc^a, SJ Shamsnia MSc^b, D Mehrabani MPH^c ^aArsanjan Azad University, Arsanjan, Iran, ^bShiraz University of Medical Sciences, Shiraz, Iran, ^cRazi Vaccine & Serum Research Institute, Shiraz University, Shiraz, Iran
317	Challenges In Pap smear screening: A qualification assessment of Provincial Health System Network E Kadivar MD^a, M Robati MD^b, M Kadkhodaei BS^c, X Ghasempour MD^b ^aDept Pediatrics & Infectious Diseases, Health Care Center, Fars Province, Shiraz, ^bDept of Obstetrics and Gynecology, Shiraz University of Medical Sciences, Fars Province, Shiraz, ^cHealth Care Center, Fars Province, Shiraz, Iran
318	MarkPap™ Kit for cervical cancer screening O Markovic MD PhD Prof, N Markovic MD PhD, P Emer BioSciCon, Inc, Rockville, MD, United States
319	MarkPap™ Test applied on specimens from solution O Markovic MD PhD Prof, N Markovic MD PhD, P Emer BioSciCon, Inc. Rockville, MD, United States